Significant Increase in Natural-killer T Cells in Patients with Tuberculosis Complicated by Type 2 Diabetes Mellitus

Author： Zhang Q   Xiao H-P   Cui H-Y   Sugawara I  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.39, Iss.1, 2011-01, pp. : 105-111

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rosiglitazone may increase the risk of chronic heart failure (HF) in patients receiving insulin for type 2 diabetes mellitus

By  

Reactions Weekly, Vol. 1, Iss. 1030, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Glitazones accelerate bone loss and increase the risk of fracture in patients with type 2 diabetes mellitus

By  

Drugs & Therapy Perspectives, Vol. 26, Iss. 1, 2010-01 ,pp. : 22-23

Adis International

Access to resources Recommend Favorite

The Pharmaceutical care of patients with type 2 diabetes mellitus

By Borges Anna  

Pharmacy World and Science, Vol. 32, Iss. 6, 2010-12 ,pp. : 730-736

Springer Publishing Company

Access to resources Recommend Favorite

Metformin does not increase in-hospital mortality, and appears to reduce morbidity for patients with type 2 diabetes mellitus undergoing heart surgery

By  

Inpharma, Vol. 1, Iss. 1579, 2007-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Pioglitazone provides greater long-term glycaemic control than glibenclamide [glyburide] in patients with type 2 diabetes mellitus (T2DM)

By  

Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite